Modified acellularization for successful vascular xenotransplantation

Journal of Korean Medical Science

Volumn 22, Issue 2, 2007, Pages 262-269

  Jo, Won Min ^a   Sohn, Young Sang ^b   Young, Ho Choi ^b   Hark, Jei Kim ^b   Hyun, Deuk Cho ^c  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

Graft rejection; Vascular endothelial cell; Xenograft

Indexed keywords

EID: 34248520621     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.2.262     Document Type: Article

References (32)

1. Kim HM, Song YJ, Sohn KH. A study on the manufacture of the artificial cardial tissue valve. Korean J Thorac Cardiovasc Surg 1979; 12: 383-94.
2. Lee JY, Oh SM, Han JI, Kim MH, Sohn KY, Kim HM, Lee IS, Kim KT, Kim YH, Lim CY, Sohn YS. Development and animal tests of artificial heart valve. Korean J Thorac Cardiovasc Surg 1987; 20: 458-72.
3. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Cardiac Surg 1987; 94: 812-23.
4. David WC, Christopher AP, Villa K, Donna M, Lee JM, Gregory JW. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994; 28: 655-66.
5. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998; 14: 279-84.
6. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000; 19: 381-6.
7. Goldstein S, inventor; Cryolife Inc, assignee. Treated tissue for implantation and methods of preparation. US patent 5,632,778. 1997.
8. Eybl E, Grimm M, Grabenwoger M, Bock P, Muller MM, Wolner E. Endothelial cell lining of bioprosthetic heart valve materials. J Thorac Cardiovasc Surg 1992; 104: 763-9.
9. Krasovskaya SM, Uzhinova LD, Andrianova MY, Prischenko AA, Livantsov MV. Biochemical and physico-chemical aspects of biomaterials calcification. Biomaterials 1991; 12: 817-20.
10. Gregory JW, Herman Y, Peter K, JM Lee, David WC. Acellular matrix allograft small caliber vascular prosthesis. ASAIO Transactions 1990; 36: 340-3.
11. Karl DS, Mustafa EB, Lora N, Richard T, Rajvir D, Emil AT. Homologous acellular matrix graft for urethral reconstruction in the rabbit: Histological and functional evaluation. J Urol 2000; 163: 1958-65.
12. Bodnar E, Olsen EG, Florio R, Dobrin J. Damage of porcine aortic valve tissue caused by the surfactant sodiumdodecylsulfate. Thorac Cardiovasc Surgeon 1986; 34: 82-5.
13. Gregory JW, David WC, Peter K, Lee JM, Herman Y. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995; 60: 353-8.
14. Jorge-Herrero E, Fernandez P, Gutierrez M, Castillo-Olivares JL. Study of the calcification of bovine pericardium: Analysis of the implication of lipids and proteoglycans. Biomaterials 1991; 12: 683-9.
15. Jorge-Herrero E, Gutierrez M, Casillo-Olivares JL. Calcification of soft tissue employed in the construction of heart valve prostheses: Study of different chemical treatment. Biomaterials 1991; 12: 249-51.
16. Tamura N, Nakamura T, Terai H, Iwakura A, Nomura S, Shimizu Y, Komeda M. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int J Artif Organs 2003; 26: 783-92.
17. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phy 2002; 24: 173-83.
18. Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, Ollerenshaw JD, Black KS, Clarke DR, O'brien MF. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001; 13 (4 Supp 1): 87-92.
19. Auchincloss H. Xenogeneic transplantation. A review. Transplantation 1988; 46: 1-20.
20. Cozzi E, Masroor S, Soin B, Vial C, White DJ. Progress in Xenotransplantation. Clin Nephrol 2000; 53: 13-8.
21. Shankarkumar U. Xenotransplantation Ethics and Immunological Hurdles! Indian J Med Sci 2003; 57: 311-8.
22. Platt JL, Fishel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swing to primate model. Transplantation 1991; 52: 214-20.
23. Dorling A, Riesbeck K, Warrens A, Lechler R. Clinical xenotransplantation of solid organs. Lancet 1997; 349: 867-71.
24. Morigi M, Zoja C, Colleoni S, Angioletti S, Imberti B, Remuzzi A, Remuzzi G. Xenogeneic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-Kappa B. Xenotransplantation 1998; 5: 57-60.
25. Alwayn IP, Appel JZ, Goepfert C, Bahler L, Cooper DK, Robson SC. Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation. Xenotransplantation 2000; 7: 247-57.
26. Fryer J, Firca J, Leventhal J, Blondin B, Malcom A, Ivancic D, Gandhi R, Shah A, Pao W, Abecassis M, Kaufman D, Stuart F, Anderson B. IgY antiporcine endothelial cell antibodies effectively block human antiporcine xenoantibody binding. Xenotransplantation 1999; 6: 98-109.
27. Joziasse DH, Oriol R. Xenotransplantation: the importance of the Gal alpha 1,3 Gal epitope in hyperacute vascular rejection. Biochem. Et Biopysica Acta 1999; 1455: 403-18.
28. Bertipaglia B, Ortolani F, Petrelli L, Gerosa G, Spina M, Pauletto P, Casarotto D, Marchini M, Sartore S. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: The VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thor Surg 2003; 75: 1274-82.
29. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprosthesis. Am J Pathol 1987; 127: 122-30.
30. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA. Calcification of subcutaneously implanted Type I collagen sponges: Effects of formaldehyde and glutaraldehyde. Am J Pathol 1986; 122: 71-82.
31. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder U, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFTTM in pediatric patients. Eur J Cardiothorac Surg 2002; 21: 703-10.
32. Cooper DK, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342: 682-3.